title: Randomised intervention study to assess the prevalence of subclinical vascular disease and hidden kidney disease and its impact on morbidity and mortality: The ILERVAS project.
abstract: OBJECTIVE
  Chronic kidney disease (CKD) and atherosclerosis are 2 interrelated diseases that increase the risk of cardiovascular morbidity and mortality. The objectives of the ILERVAS project are: 1) to determine the prevalence of subclinical arterial disease and hidden kidney disease; 2) to assess the impact of early diagnosis of both diseases on cardiovascular morbidity and mortality and also on the progression of CKD; 3) to have a platform of data and biological samples.
  
  
  METHODS
  Randomized intervention study. From 2015 to 2017, 19,800 people (9,900 in the intervention group and 9,900 in the control group) aged between 45 and 70 years without previous history of cardiovascular disease and with at least one cardiovascular risk factor will be randomly selected from the primary health care centres across the province of Lérida. A team of experts will travel around in a mobile unit to carry out the following baseline tests on the intervention group: Artery ultrasound; (carotid, femoral, transcranial and abdominal aorta); ankle-brachial index; spirometry; determination of advanced glycation end products; dried blood spot and urine spot tests. Additionally, blood and urine samples will be collected and stored in the biobank to identify new biomarkers using omics studies. Participants will be followed up until 2025 for identification of cardiovascular events, treatment changes and changes in lifestyle.
  
  
  CONCLUSIONS
  The ILERVAS project will reveal the prevalence of subclinical vascular disease and hidden kidney disease, determine whether or not their early diagnosis brings health benefits and will also allow investigation of new risk factors.
authors.affiliation: Institut de Recerca Biomèdica (IRBLleida), Lérida, España; Unidad de Diagnóstico y Tratamiento Enfermedades Aterotrombóticas (UDETMA), Servicio de Nefrología, Hospital Universitari Arnau de Vilanova, Lérida, España.
authors.forename: Àngels
authors.initials: À
authors.lastname: Betriu
authors.affiliation: Área Básica de Salut Borges Blanques, Lérida, España.
authors.forename: Cristina
authors.initials: C
authors.lastname: Farràs
authors.affiliation: Institut de Recerca Biomèdica (IRBLleida), Lérida, España.
authors.forename: María
authors.initials: M
authors.lastname: Abajo
authors.affiliation: Departamento Bioestadística, IRBLleida, Lérida, España.
authors.forename: Montserrat
authors.initials: M
authors.lastname: Martinez-Alonso
authors.affiliation: Servicio de Nefrología, Hospital Universitari Arnau de Vilanova, Lérida, España.
authors.forename: David
authors.initials: D
authors.lastname: Arroyo
authors.affiliation: Servicio de Neumología, Hospital Universitari Arnau de Vilanova, Lérida, España; Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES), Madrid, España.
authors.forename: Ferran
authors.initials: F
authors.lastname: Barbé
authors.affiliation: Dirección de Atención Primaria, Lérida, España.
authors.forename: Miquel
authors.initials: M
authors.lastname: Buti
authors.affiliation: Servicio de Endocrinología, Hospital Universitari Arnau de Vilanova, Lérida, España.
authors.forename: Albert
authors.initials: A
authors.lastname: Lecube
authors.affiliation: Grupo de Fisiopatología Metabólica, Departamento de Medicina Experimental, IRBLleida, Lérida, España.
authors.forename: Manuel
authors.initials: M
authors.lastname: Portero
authors.affiliation: Servicio de Neurología, Hospital Universitari Arnau de Vilanova, Lérida, España.
authors.forename: Francisco
authors.initials: F
authors.lastname: Purroy
authors.affiliation: Servicio de Medicina Interna, Hospital Universitari de Santa María, Lérida, España.
authors.forename: Gerard
authors.initials: G
authors.lastname: Torres
authors.affiliation: Institut de Recerca Biomèdica (IRBLleida), Lérida, España; Laboratorio de Nefrología Experimental, IRBLleida, Lérida, España.
authors.forename: José Manuel
authors.initials: JM
authors.lastname: Valdivielso
authors.affiliation: Institut de Recerca Biomèdica (IRBLleida), Lérida, España; Unidad de Diagnóstico y Tratamiento Enfermedades Aterotrombóticas (UDETMA), Servicio de Nefrología, Hospital Universitari Arnau de Vilanova, Lérida, España; Servicio de Nefrología, Hospital Universitari Arnau de Vilanova, Lérida, España. Electronic address: edfernandez.lleida.ics@gencat.cat.
authors.forename: Elvira
authors.initials: E
authors.lastname: Fernández
mesh_terms: D000368:Aged; D055109:Ankle Brachial Index; D001157:Arterial Occlusive Diseases / Q000000981:diagnostic imaging; D058070:Asymptomatic Diseases; D018070:Biological Specimen Banks; D015415:Biomarkers / Q000097:blood / Q000652:urine; D002318:Cardiovascular Diseases / Q000453:epidemiology* / Q000401:mortality; D042241:Early Diagnosis; D005260:Female; D005500:Follow-Up Studies; D017127:Glycation End Products, Advanced / Q000097:blood; D006801:Humans; D007674:Kidney Diseases / Q000175:diagnosis* / Q000453:epidemiology; D008297:Male; D008875:Middle Aged; D008952:Mobile Health Units; D015995:Prevalence; D011446:Prospective Studies; D011897:Random Allocation; D012307:Risk Factors; D013030:Spain / Q000453:epidemiology; D013147:Spirometry; D018608:Ultrasonography, Doppler; D014652:Vascular Diseases / Q000175:diagnosis* / Q000453:epidemiology
chemical_list: D015415:Biomarkers; D017127:Glycation End Products, Advanced
keywords: Atherosclerotic plaque; Biomarcadores; Biomarkers; Capacidad pulmonar; Cardiovascular disease; Diagnóstico precoz; Early diagnosis; Enfermedad cardiovascular; Enfermedad renal oculta; Hidden kidney disease; Lung capacity; Placa de ateroma; Prevención; Prevention